Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-19-006096
Filing Date
2019-06-21
Accepted
2019-06-21 16:43:39
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2015955
2 GRAPHIC g764780g01n20.jpg GRAPHIC 56360
3 GRAPHIC g764780g02b30.jpg GRAPHIC 50497
4 GRAPHIC g764780g08k16.jpg GRAPHIC 70182
5 GRAPHIC g764780g10k96.jpg GRAPHIC 153714
6 GRAPHIC g764780g26h32.jpg GRAPHIC 55030
7 GRAPHIC g764780g34v81.jpg GRAPHIC 87801
8 GRAPHIC g764780g37q95.jpg GRAPHIC 84917
9 GRAPHIC g764780g44g10.jpg GRAPHIC 77420
10 GRAPHIC g764780g46g59.jpg GRAPHIC 29062
11 GRAPHIC g764780g62b12.jpg GRAPHIC 87008
12 GRAPHIC g764780g81r38.jpg GRAPHIC 95885
  Complete submission text file 0000950123-19-006096.txt   3185982
Mailing Address 1337 3RD AVENUE SAN FRANCISCO CA 94122
Business Address 1337 3RD AVENUE SAN FRANCISCO CA 94122 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02704 | Film No.: 19912008
SIC: 2834 Pharmaceutical Preparations